Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 10, 2022

SELL
$3.02 - $4.56 $1,709 - $2,580
-566 Reduced 71.83%
222 $1,000
Q1 2022

May 12, 2022

SELL
$3.92 - $7.48 $18,753 - $35,784
-4,784 Reduced 85.86%
788 $4,000
Q4 2021

Feb 10, 2022

BUY
$6.7 - $11.38 $20,904 - $35,505
3,120 Added 127.24%
5,572 $40,000
Q3 2021

Nov 10, 2021

BUY
$10.11 - $17.56 $24,789 - $43,057
2,452 New
2,452 $26,000

Others Institutions Holding ICAD

About ICAD INC


  • Ticker ICAD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 25,333,900
  • Market Cap $42.6M
  • Description
  • iCAD, Inc. provides image analysis, workflow solutions, and radiation therapy for the treatment of cancer in the United States. It operates through two segments, Cancer Detection and Cancer Therapy. The company offers PowerLook platform, which hosts the AI algorithm solutions and manages the communications between imaging acquisition systems, an...
More about ICAD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.